Published Date:2021-12-13 Original Link:https://www.onenessbio.com/en/news_detail128_1.htm No 1 Date of announcement 2021/12/12 Time of announcement 16:56:09 Subject The partial efficacy data for the Phase 2a study of FB825 in the treatment of atopic dermatitis in the U.S. have been analyzed To which item it meets paragraph 10 Date of events 2021/12/11 Statement 1.Product:FB825 anti-CεmX humanized...Read More
Published Date:2021-12-03 Original Link:https://www.onenessbio.com/en/news_detail127_1.htm No 1 Date of announcement 2021/12/03 Time of announcement 16:56:09 Subject The mechanism of action and Phase 3 MRCT results of the diabetic foot ulcer new drug, Fespixon have been accepted for an oral presentation at IDF Congress 2021 To which item it meets paragraph 12 Date of events 2021/12/03 Statement...Read More
Published Date:2021-12-02 Original Link:https://www.onenessbio.com/en/news_detail126_1.htm No 1 Date of announcement 2021/12/01 Time of announcement 18:25:04 Subject Oneness Biotech Co., Ltd. receives a Taiwan patent O titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” O on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2021/12/01 Statement 1.Date of occurrence...Read More
Published Date:2021-10-22 Original Link:https://www.onenessbio.com/en/news_detail65_1.htm No 2 Date of announcement 2021/10/22 Time of announcement 17:11:00 Subject Oneness Biotech Co., LTD. receives a Mexican patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2021/10/22 Statement 1.Date of occurrence of the...Read More
Published Date:2021-10-19 Original Link:https://www.onenessbio.com/en/news_detail64_1.htm No 2 Date of announcement 2021/10/19 Time of announcement 17:24:01 Subject An Australian patent on the producing of recombinant glycoproteins with modified glycosylation was granted. To which item it meets paragraph 53 Date of events 2021/10/19 Statement 1.Date of occurrence of the event:2021/10/19 2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the...Read More
Published Date:2021-10-13 Original Link:https://www.onenessbio.com/en/news_detail63_1.htm No 1 Date of announcement 2021/10/13 Time of announcement 17:22:30 Subject A Malaysian patent on the Anti-CεMx (FB825) antibody was granted. To which item it meets paragraph 53 Date of events 2021/10/13 Statement 1.Date of occurrence of the event:2021/10/13 2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the Company (please enter ”head...Read More
Published Date:2021-10-12 Original Link:https://www.onenessbio.com/en/news_detail62_1.htm No 2 Date of announcement 2021/10/11 Time of announcement 15:56:19 Subject Oneness has been notified by the US FDA on the acceptance of ON101 medical device 510(k) application To which item it meets paragraph 10 Date of events 2021/10/09 Statement 1.Product:ON101 Medical Device 2.Mass production date:NA 3.Effect on company...Read More
